San Francisco, California–(Newsfile Corp. – March 3, 2026) – DIMERx, Inc. (“DIMERx” or “the Company”), is a clinical-stage biopharmaceutical company dedicated to addressing the public-health crisis of drug abuse and dependence, with a portfolio of first-in-class, dimer-based pain therapeutics engineered to deliver effective analgesia without the addiction liabilities of conventional …
Read More »
Matribhumi Samachar English